Effectiveness of Azithromycin as add-on Therapy in COVID-19 Management.

摘要: As winter is knocking the door, risk of respiratory tract infection increasing at present scenario due to no prophylaxis Covid-19. So, one safe until everyone safe. Worldwide researchers are looking for vaccine remove need social distancing, mask-wearing and gathering. A like many other outcomes if would be available; we cannot say about effectiveness vaccine. Several drugs testing save people life from pandemic; azithromycin them. This work a review article with updated findings in context COVID-19. The option regards COVID-19 justified by its anti-inflammatory, immunomodulatory, anti-fibrotic effects their pharmacokinetic properties, leading effective concentrations target tissue. Azithromycin tends an candidate SARS-CoV-2 replication inhibition that block initial stage viral cycle. Clinical trials preliminary scale final show significant results supportive care therapy. was early medication Covid-19 or without hydroxychloroquine. It exercised mostly as outpatient antibiotic In summing-up, any primary anti-viral treatment not only possibility fighting pharmacologically. will injustice them who require broader spectrum do exercise So research priority needed determine whether useful